Cargando...
Fibroblast Growth Factor 23 and Acute Kidney Injury
Fibroblast growth factor 23 (FGF23) which is produced in bone, participates in the maintenance of phosphate metabolism and can serve as a biomarker for cardiovascular adverse outcomes in patients with chronic kidney and end-stage renal disease. Circulating FGF23 rapidly increases after acute kidney...
Guardado en:
| Publicado en: | Pediatr Nephrol |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4458234/ https://ncbi.nlm.nih.gov/pubmed/25480729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-014-3006-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|